USPTO 2015–2025 USPTO PatentsView US Corporation

Eridan Communications, Inc.

USPTO PatentsView assignee record - 24 granted patents across 16 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H03F (Amplifiers).

RSS updates for this company

The verdict

According to USPTO PatentsView, Eridan ranks #12,434 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 16 technology areas.

#12,434
of 49,997 US assignees by volume
Top 38%
by Innovation Score (39.3/100)
16.0
avg claims per patent
+56%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12434 · US Corporation #12,434 · 24 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 24 grants
  • UPPER-Q #12,434/49,997
  • PHOTO-FINISH Elixir Medical
  • CPC-FOCUS H03F · 16 areas
  • INNOV-THIN 39.3/100
  • CLAIMS-RICH 16.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +56% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Elixir Medical Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Eridan’s 39.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Eridan

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Eridan's Innovation Score is 39.3/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Eridan?

Each dot is one of Eridan’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Eridan’s own 16.0 claims/patent is ABOVE the 14.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Eridan vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 23.923.92424.1 010203040 Granted patents (volume) Avg claims / patent Elixir Medical Corporation - 24, 35.08Elixir MedicalEnsign-Bickford Aerospace & Defense Company - 24, 14.71Ensign-bickford A…Epic Tech, LLC - 24, 20.21Epic TechErgomotion, Inc. - 24, 10.29ErgomotionEversight, Inc. - 24, 14.08EversightExcillum AB - 24, 15.71Excillum ABF-tech Inc. - 24, 7.08F-techFTI Group (HOLDING) Company Limited - 24, 11.92FTI Group (Holdin…Eridan Communications, Inc. - 24, 15.96Eridan Communicat…
Eridan vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Eridan's grants concentrate

Eridan Communications, Inc. is a focused PatentsView assignee: 16 CPC subclasses with 62.5% of grants classified under H03F (Amplifiers). Peak complete grant year is 2020 (6 grants) versus a trough of 1 in 2017. By volume, Eridan sits between Elixir Medical Corporation and FTI Group (HOLDING) Company Limited.

Eridan's three-year grant acceleration

Eridan Communications, Inc. shows 6 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Eridan's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Eridan holds 24 patents at rank #12,438, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Eridan

By rank, the assignees closest to #12,438 in granted patent volume.

Leaders in H03F (Amplifiers)

Other assignees with the most granted patents in Eridan's primary technology class.

Eridan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 38% higher than 62% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2016201720182019202020212022202320242025 1
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Eridan Communications, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 4 16.7%
2017 1 4.2%
2018 3 12.5%
2019 1 4.2%
2020 6 25.0%
2021 2 8.3%
2022 3 12.5%
2023 1 4.2%
2024 2 8.3%
2025partial year 1 4.2%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Eridan Communications, Inc.'s patent record in context - here's where to go next.

  • Eridan Communications, Inc.'s lead technology class is H03F (Amplifiers), 62.5% of its portfolio - see every assignee active in that class. Explore H03F
  • Ranked #12,434 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Eridan Communications, Inc. against Elixir Medical Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 39.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.